Skip to main content
Fig. 2 | Cancer Nanotechnology

Fig. 2

From: Preferential drug delivery to tumor cells than normal cells using a tunable niosome–chitosan double package nanodelivery system: a novel in vitro model

Fig. 2

Chitosan diffusion: a, b IOSE-121 normal cells incubated for 1 h in the presence of chitosan. c, d OV2008 tumor cells incubated for 1 h in the presence of chitosan. e, f IOSE-121 and OV2008 incubated in medium only. g Mean DIC signal intensity shows 1.75 times higher levels of intensity around OV2008 cells than around IOSE-121 cells. The background signal intensity is represented by the cell controls incubated in the medium alone. Error bars: ± 1 SD. *Represents statistically significant difference (unpaired t-test, p < 0.05)

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us